Inhaled corticosteroids and pneumonia mortality in COPD patients

被引:0
|
作者
Almagro, Pere [1 ]
Martinez-Camblor, Pablo [2 ]
Soriano, Joan B. [3 ,4 ]
机构
[1] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Multimorbid Patients Unit, Barcelona, Spain
[2] Geisel Sch Med Dartmouth, Hanover, NH USA
[3] Univ Autonoma Madrid, Hosp Univ Princesa IISP, Madrid, Spain
[4] Inst Salud Carlos III, CIBERES, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
关键词
OBSTRUCTIVE PULMONARY-DISEASE; DOUBLE-BLIND; FLUTICASONE FUROATE; SALMETEROL-FLUTICASONE; PARALLEL-GROUP; EXACERBATIONS; RISK; COMBINATION; VILANTEROL; QVA149;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?
    Restrepo, M. I.
    Mortensen, E. M.
    Anzueto, A.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 1 - 3
  • [32] Inhaled Corticosteroids and Mortality in COPD Biases in Randomized Trials
    Suissa, Samy
    CHEST, 2022, 162 (06) : E333 - E334
  • [33] Pneumonia risk in COPD patients on long term inhaled corticosteroids - Data from the European COPD audit<%
    Saleh, Aarash
    Lopez-Campos, Jose
    Hartl, Sylvia
    Pozo-Rodriguez, Francisco
    Roberts, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [34] Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators
    Mapel, Douglas
    Schum, Michael
    Yood, Marianne
    Brown, Jeffrey
    Miller, David
    Davis, Kourtney
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 109 - 117
  • [35] Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
    Ridolo E.
    Incorvaia C.
    Martignago I.
    Pessina L.
    Lauretani F.
    Loperfido L.
    Riario-Sforza G.G.
    Broglia A.
    Gritti B.L.
    Panella L.
    Clinical and Molecular Allergy, 16 (1)
  • [36] Pneumonia Risk in Patients with COPD with High Blood Eosinophilia: How Does Impact Inhaled Corticosteroids to Development of Pneumonia in Such Patients?
    Sadigov, A. S.
    Akhundov, S.
    Mammadova, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [37] Inhaled corticosteroids and COPD
    Farquhar, D
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 163 (03) : 326 - 327
  • [38] Inhaled corticosteroids and rate of exacerbations in patients with COPD
    Beauchesne, MF
    Lalande, M
    Fillion, A
    Blais, L
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (05) : 973 - 974
  • [39] INHALED CORTICOSTEROIDS AND PNEUMONIA
    Lunca, Catalina
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (04): : 1042 - 1042
  • [40] The risk and outcomes of pneumonia in patients on inhaled corticosteroids
    Sibila, Oriol
    Soto-Gomez, Natalia
    Restrepo, Marcos I.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 32 : 130 - 136